No abstract available
MeSH terms
-
Advisory Committees
-
Decision Making
-
Evidence-Based Medicine
-
Guidelines as Topic
-
Health Policy
-
Humans
-
Male
-
Mass Screening / standards*
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / blood*
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / therapy
-
Randomized Controlled Trials as Topic
-
Reproducibility of Results
-
Risk
Substances
-
Prostate-Specific Antigen